BioProgress set to launch NRobe technology 30/11/2006 By Anna Lewcock In-PharmaTechnologist.com BioProgress last week announced an update to their agreement with licensing partner FMC Corporati

Current Trends and Challenges in the Excipients Market Oct 1, 2006 By: James Taylor Pharmaceutical Technology Current Trends and Challenges in the Excipients Market

Development and validation of an HPLC-uv method for the determination of gatifloxacin in bulk material, pharmaceutical formulations, human plasma and metal complexes. 2006 Oct Sultana N, Arayne MS

Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations Received 8 March 2006; revised 30 June 2006; accepted 4 July 2006. Availab

Ephemeral profiles of prescription drug and formulation tampering: Evolving pseudoscience on the Internet 3 February 2006 Edward J. Cone Drug and Alcohol Dependence Abstract The magnitude of n

Excipient Manufacturers and Pharmaceutical Companies Raise Concerns Over Guidelines for Genotoxic Impurities Nov 3, 2006 By: Patricia Van Arnum Pharmaceutical Technology AAPS, San Antonio (O

Excipient quantitation and drug distribution during formulation optimization 17 February 2006 Robert Forget, and Suzanne Spagnoli Journal of Pharmaceutical and Biomedical Analysis Abstract A

Excipient-Excipient Interactions in Pharmaceutical Systems Intended for Topical Application Jun 1, 2005 Ryan F Donnelly, Paul A. McCarron, Gavin P. Andrews, A. David Woolfson Pharmaceutical

Eye on excipients: Excipients in the regulatory environment July 2005 John A. McCarty A discussion of how regulatory agencies, national pharmacopoeias, and trade groups influence the acceptance a

Factorial designed experiment to study the effects of excipients on the mechanical properties of pellets October 2006 Bashaiwoldu, Abraham; Podczeck, Fridrun: Newton, J. Michael ingenta connect

Functionality and Performance of Excipients Oct 1, 2006 By: R. Christian Moreton Pharmaceutical Technology The objective of a medicinal formulation development project is to deliver dr

Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo 10 May 2004 Gilles Cornaire, John Woodley, Philippe Hermann, Alix Cloarec, C?cile Arellano and Georges Houi

Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations Received: 29 November 2005; Revised: 13 April 2006; Accepted: 2 May 2006 J. Wardrop 1 *, D. Law 1

Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles June 2006 Yogesh K. Katare and Amulya K. Panda European Journal of Pharmaceutical S

Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage 18 April 2006 Wassim Abdelwahed, Ghania Degobert and Hatem Fessi European Journal of Pharmaceu

Manufacturing affects protein performance 09/08/2006 By Gregory Roumeliotis In-PharmaTechnologist.com The excipients used in a protein formulation and the method of production can impact not j

Multivariate Methods in the Development of a New Tablet Formulation: Excipient Mixtures and Principal Properties 2006 Jon Gabrielsson A1, Michael Sjàstràm A1, Nils-Olof Lindberg A2, Ann-Christin P

Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique 6 March 2006 D. Douroumis and A. Fahr European Journal of Pharmaceutics and Biopharmace

New Excipient Guidance Doesn?t Fill Regulatory Gap May 27, 2005 Laura Bush Pharmaceutical Technology The US Food and Drug Administration (Rockville, MD) issued a final guidance this mon

New Tate and Lyle excipient bypasses wet granulation June 7, 2006 By Stephen Daniells and Gregory Roumeliotis in-pharma 06/07/2006 - Tate and Lyle has announced the launch of Meritab - a new dir

Orally Disintegrating Tablets Apr 20, 2006 William R. Pfister, Tapash K. Ghosh PharmTech Asia Over the past three decades, orally disintegrating tablets (ODTs) have gained much attent

Photo-induced proton gradients and ATP biosynthesis produced by vesicles encapsulated in a silica matrix Engineering Village 2 2006 Elsevier Inc. Accession number: 8546885 Title: Photo-in

Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets 13 September 2005 Rafael Barreiro-Iglesias, Lev Bromberg, Marina Temchenko, T. Alan Hatton

Robustness Testing of a Tablet Formulation Using Multivariate Design 2006 Jon Gabrielsson A1, Michael Sjàstràm A1, Nils-Olof Lindberg A2, Ann-Christin Pihl A2, Torbjàrn Lundstedt A3 Drug Develop

Rotary spray congealing of a suspension: Effect of disk speed and dispersed particle properties. 2006 Nov Mackaplow MB, Zarraga IE, Morris JF. J Microencapsul. PubMed Abbott Laboratories, Glob

Screening of Novel Excipients for Improving the Stability of Retroviral and Adenoviral Vectors Accepted for publication February 22, 2006. Web Release Date: March 16, 2006 Biotechnol. Prog. ACS

The Applications - BioPharm International Mar 10, 2006 BioPharm International As we've shown, biopharmaceutical companies have many options when they choose an expression system: bacteria, ye

The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers 21 September 2005 Yon

The Role of Excipients in the Control of Dehydroepiandrosterone Inclusion Complex Delivery 2006 Bergamante, Valentina; Gian Carlo Ceschel; Simone Lombardi Borgia; Ronchi, Celestino; Fini, Adamo i

The Role of Reverse Engineering in the Development of Generic Formulations Apr 20, 2006 Arvind K. Bansal, Vishal Koradia PharmTech Asia The authors propose a decision-tree approach

Towards a molecular characterization of pharmaceutical excipients: Mass spectrometric studies of ethoxylated surfactants 25 April 2006 Klaus Raith, Christian E.H. Schmelzer and Reinhard H.H. Neube

Viability and biological properties of probiotic vaginal lactobacilli after lyophilization and refrigerated storage into gelatin capsules 1 April 2006 Gabriela Z?rate and Mar?a Elena Nader-Macias